欧盟 - 爱沙尼亚文 - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastilised ained - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

欧盟 - 爱沙尼亚文 - EMA (European Medicines Agency)

theravia - hüdroksükarbamiid - aneemia, sickle cell - antineoplastilised ained - siklos on näidustatud ennetamine korduvate valus vaso-occlusive kriiside, sealhulgas ägeda rinnus sündroom lastel ja täiskasvanud patsientidel, kes põevad sümptomaatiline sirprakuline sündroom.

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

bayer ag - gadopenteethape - süstelahus - 469mg 1ml 5ml 10tk; 469mg 1ml 15ml 1tk; 469mg 1ml 20ml 10tk; 469mg 1ml 10ml 10tk; 469mg 1ml 5ml 1tk

欧盟 - 爱沙尼亚文 - EMA (European Medicines Agency)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - suguhormoonid ja immunoglobuliinid, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.

欧盟 - 爱沙尼亚文 - EMA (European Medicines Agency)

pharmaswiss ceska republika s.r.o - pegaptaniib - märg macula degeneration - oftalmoloogilised vahendid - macugen on näidustatud neovaskulaarse (märg) vanusega seotud makulaarse degeneratsiooni (amd) raviks.

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

qilu pharma spain s.l. - meropeneem - süste-/infusioonilahuse pulber - 1000mg 1tk

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

fresenius kabi polska sp. z o.o. - tsisatrakuurium - süste-/infusioonilahus - 2mg 1ml 10ml 1tk; 2mg 1ml 10ml 50tk; 2mg 1ml 2.5ml 5tk; 2mg 1ml 10ml 5tk; 2mg 1ml 5ml 1tk; 2mg 1ml 2.5ml 1tk; 2mg 1ml 2.5ml 50tk; 2mg 1ml 5ml 50tk; 2mg 1ml 10ml 10tk

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

fresenius kabi polska sp. z o.o. - tsisatrakuurium - süste-/infusioonilahus - 5mg 1ml 30ml 5tk; 5mg 1ml 30ml 1tk

欧盟 - 爱沙尼亚文 - EMA (European Medicines Agency)

cis bio international - yttrium (90y) chloride - radionukliidi pildistamine - diagnostilised radiofarmatseutilised ühendid - kasutada ainult spetsiaalselt välja töötatud ja radioloogilise märgistamise jaoks selle radionukliidiga kandev-molekulide radiomärgistamiseks. radiopharmaceutical precursor - not intended for direct application to patients.

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

vitabalans oy - loperamiid - õhukese polümeerikattega tablett - 2mg 8tk